RUBY - Rubius Therapeutics' (RUBY) CEO Pablo Cagnoni on Q4 2019 Results - Earnings Call Transcript
Rubius Therapeutics, Inc. (RUBY)
Q4 2019 Earnings Conference Call
March 12, 2020 8:00 AM ET
Company Participants
Lori Melançon – Vice President of Corporate Communications and Investor Relations
Pablo Cagnoni – Chief Executive Officer
Christina Coughlin – Chief Medical Officer
Laurence Turka – Chief Scientific Officer
Andy Oh – Chief Financial Officer
Conference Call Participants
Michael Yee – Jefferies
Michael Schmidt – Guggenheim
Jonathan Chang – SVB Leerink
Matthew Harrison – Morgan Stanley
Jessica Fye – JPMorgan
Presentation
Operator
Good morning and welcome to the Rubius Therapeutics Fourth Quarter and Full Year 2019 Financial Results